BioArctic

319.80 SEK

+0.50%

Less than 1K followers

BIOA B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioArctic

2019202020212022202320242025
Revenue281.862.323.1228.3616.0257.41,999.1
growth-%-77.9 %-62.9 %886.3 %169.8 %-58.2 %676.8 %
EBITDA121.7-74.0-126.6-2.8271.1-171.11,271.6
EBIT112.5-85.0-139.7-17.4252.6-228.51,258.8
Profit before taxes113.0-86.7-140.5-11.2276.5-189.51,255.6
Net income88.5-68.5-119.8-11.2229.3-177.11,022.3
EPS1.00-0.78-1.36-0.132.60-2.0011.55
Dividend0.000.000.000.000.000.002.00
Dividend ratio0.0 %-0.0 %-0.0 %-0.0 %0.0 %-0.0 %17.3 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%43.2 %-118.7 %-547.0 %-1.2 %44.0 %-66.5 %63.6 %
EBIT-%39.9 %-136.4 %-603.7 %-7.6 %41.0 %-88.8 %63.0 %
ROE9.1 %-7.6 %-15.2 %-1.4 %21.9 %-19.8 %52.0 %
ROI7.5 %-6.5 %-13.3 %-1.3 %19.3 %-15.9 %39.7 %